Adrian Gottschalk - May 26, 2023 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Executive Officer, Director
Signature
/s /Allan Reine, M.D., Attorney-in-Fact for Adrian Gottschalk
Stock symbol
FHTX
Transactions as of
May 26, 2023
Transactions value $
$0
Form type
4
Date filed
5/31/2023, 09:22 PM
Previous filing
Jan 30, 2023
Next filing
Aug 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Gift $0 -300K -40.07% $0.00 449K May 26, 2023 See Footnote F1, F2
transaction FHTX Common Stock Gift $0 +300K +201.74% $0.00 449K May 26, 2023 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 26, 2023, 300,000 shares of the Issuer's Common Stock were transferred from the Adrian H. Gottschalk Living Trust dated September 8, 2009 to the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023. This was a bona fide gift with no payment in consideration.
F2 Consists of 300,000 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary, 110,690 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 38,014 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.